Erik Matson reflects on John Callanan’s new book about Bernard Mandeville, and the controversial theories that he promoted in ...

New partnerships and major investment are helping Glenalmond College strengthen its academic performance, innovative facilities and long-term success ...

New partnerships and major investment are helping Glenalmond College strengthen its academic performance, innovative facilities and long-term success ...

What are the latest Fortnite map POIs? The Fortnite island has become somewhat iconic over the years, with classic landing spots like Dusty Depot and Pleasant Park still bringing warm, nostalgic joy ...

Sanofi says it has reached an agreement with Dren Bio that would see it take control of autoimmune disease treatment DR-0201, a bispecific antibody-based myeloid cell engager with the potential to ...

InvestingPro data reveals the stock typically moves counter to market trends with a beta of -1.25, potentially offering diversification benefits for investors seeking biotech exposure. In other recent ...

Investment intended to fuel advancement of novel Platelet-derived Regenerative Biologic therapy for Sjogren's disease dry eye and other ocular surface diseases Led by Ziff Capital Partners and joined ...

nChroma Bio Announces First Patient Dosed in Phase 1/2 Clinical Trial of Epigenetic Silencer CRMA-1001 for Chronic Hepatitis B Clinical trial authorizations obtained from New Zealand and the United ...

Molecular Biology is the field of biology that studies the composition, structure and interactions of cellular molecules such as nucleic acids and proteins that carry out the biological processes ...

Synthetic biology is the design and construction of new biological parts, devices, and systems, and the re-design of existing, natural biological systems for useful purposes. New-to-nature ...

Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic ...

After capturing the North American market with Wegovy (semaglutide) and Zepbound (tirzepatide), Novo Nordisk A/S and Eli Lilly and Co. are advancing blockbuster glucagon-like peptide-1 (GLP-1) ...